[Audio] Our team includes Prof Larry Chow, a Harvard-trained biochemist. Co-inventor Prof Bill Chan, a world-renowned synthetic chemist. C-E-O--, Dr Gigi Sun and Dr Iris Wong. We expect to complete the detailed animal efficacy and toxicity study in 2025 and following with filing of Investigational New Drug application.. 

Scene 1

Prof. Larry, Chow Ming-Cheung Chairperson (shareholder) Head (ABCT)&Professor (PolyU)

Dr. Gege Sun CEO (Shareholder) Research and Development Postdoctoral fellow (PolyU)

Prof. Bill, Chan Tak-hang Scientific Advisor  (Shareholder) Professor (McGill)

Dr. Iris Wong, Lai-king Scientific Advisor  (Shareholder) Scientific Officer (PolyU)

Cellular, mechanism and animal studies of flavonoid dimers in reversing DOX resistance.

Patent filing. Apply for incubation program in PolyU and HKSTP.

Completing animal efficacy and toxicity studies. Filing Investigational New Drug (IND)

Our team and milestones

Our team includes Prof Larry Chow, a Harvard-trained biochemist. Co-inventor Prof Bill Chan, a world-renowned synthetic chemist. C-E-O--, Dr  Gigi Sun and Dr  Iris Wong. We expect to complete the detailed animal efficacy and toxicity study in 2025 and following with filing of Investigational New Drug application.